HK1080373A1 - Solid dispersion comprising two different polymer matrixes - Google Patents

Solid dispersion comprising two different polymer matrixes

Info

Publication number
HK1080373A1
HK1080373A1 HK06100333A HK06100333A HK1080373A1 HK 1080373 A1 HK1080373 A1 HK 1080373A1 HK 06100333 A HK06100333 A HK 06100333A HK 06100333 A HK06100333 A HK 06100333A HK 1080373 A1 HK1080373 A1 HK 1080373A1
Authority
HK
Hong Kong
Prior art keywords
solid dispersion
different polymer
polymer matrixes
matrixes
different
Prior art date
Application number
HK06100333A
Other languages
English (en)
Inventor
Karel Six
Geert Verreck
Jozef Peeters
Marcus Ell Brewster
Guy Van Den Mooter
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1080373A1 publication Critical patent/HK1080373A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
HK06100333A 2002-07-04 2006-01-09 Solid dispersion comprising two different polymer matrixes HK1080373A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0207422 2002-07-04
PCT/EP2003/006999 WO2004004683A1 (en) 2002-07-04 2003-07-01 Solid dispersions comprising two different polymer matrixes

Publications (1)

Publication Number Publication Date
HK1080373A1 true HK1080373A1 (en) 2006-04-28

Family

ID=30011034

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100333A HK1080373A1 (en) 2002-07-04 2006-01-09 Solid dispersion comprising two different polymer matrixes

Country Status (10)

Country Link
US (1) US7407670B2 (no)
EP (1) EP1521571A1 (no)
JP (1) JP2005538973A (no)
CN (1) CN1318019C (no)
AU (1) AU2003246351B2 (no)
CA (1) CA2489071A1 (no)
HK (1) HK1080373A1 (no)
NO (1) NO20050506L (no)
NZ (1) NZ536975A (no)
WO (1) WO2004004683A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US7927703B2 (en) * 2003-04-11 2011-04-19 3M Innovative Properties Company Adhesive blends, articles, and methods
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
EP1765350B1 (en) * 2004-06-24 2011-05-18 CTC Bio, Inc. Manufacturing method of solid dispersion containing itraconazole
US20090317355A1 (en) * 2006-01-21 2009-12-24 Abbott Gmbh & Co. Kg, Abuse resistant melt extruded formulation having reduced alcohol interaction
US20090022798A1 (en) * 2007-07-20 2009-01-22 Abbott Gmbh & Co. Kg Formulations of nonopioid and confined opioid analgesics
US20100172989A1 (en) * 2006-01-21 2010-07-08 Abbott Laboratories Abuse resistant melt extruded formulation having reduced alcohol interaction
US7872560B2 (en) * 2007-03-19 2011-01-18 Abc Taiwan Electronics Corp. Independent planar transformer
DK2200588T3 (da) * 2007-09-25 2019-07-01 Solubest Ltd Sammensætninger, som omfatter lipofile aktive forbindelser, og fremgangsmåde til fremstilling deraf
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
EP2105130A1 (de) * 2008-03-25 2009-09-30 Ratiopharm GmbH Pharmazeutische Formulierung und Verfahren zu deren Herstellung
EP2133068A1 (de) * 2008-06-13 2009-12-16 Ratiopharm GmbH Verfahren zur Auswahl eines geeigneten Hilfsstoffs für die Herstellung von festen Dispersionen für pharmazeutische Formulierungen
EP2568968B1 (en) 2010-05-10 2017-07-12 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
US9901540B2 (en) 2010-05-10 2018-02-27 Euro-Celtique S.A. Combination of active loaded granules with additional actives
CN102946870A (zh) 2010-05-10 2013-02-27 欧洲凯尔特公司 包含氢吗啡酮和纳洛酮的药物组合物
EP2651519B1 (en) 2010-12-13 2020-08-05 Colgate-Palmolive Company Oral compositions and method for producing thereof
KR20140006879A (ko) 2011-02-17 2014-01-16 에프. 호프만-라 로슈 아게 고온 용융 압출에 의해 활성 약학 성분을 과냉된 액체 상태로부터 제어되는 방식으로 결정화시키는 방법
WO2012129072A1 (en) 2011-03-18 2012-09-27 Particle Dynamics International, Llc Solid particulate compositions comprising coenzyme q10
EP2739269A2 (en) 2011-08-01 2014-06-11 Ranbaxy Laboratories Limited Dissolution enhanced controlled drug delivery system for poorly water soluble drugs
WO2013030789A1 (en) 2011-08-30 2013-03-07 Ranbaxy Laboratories Limited Pharmaceutical oral solid dosage form containing a poorly water soluble pde - iv inhibitor
US9889222B2 (en) 2011-11-09 2018-02-13 Kimberly-Clark Worldwide, Inc. Aqueous medium-sensitive coating compositions for triggered release of active ingredients and visual indication for wetness
US8791045B2 (en) 2011-11-09 2014-07-29 Kimberly-Clark Worldwide, Inc. Non-tacky wetness indicator composition for application on a polymeric substrate
US9585826B2 (en) 2012-11-07 2017-03-07 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of active chemistry
US9119780B2 (en) 2013-10-30 2015-09-01 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of proactive chemistry
WO2015071380A1 (en) 2013-11-13 2015-05-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
CN104721141A (zh) * 2013-12-18 2015-06-24 博瑞生物医药技术(苏州)有限公司 抗真菌药物固体分散体
US11372041B2 (en) * 2020-12-02 2022-06-28 Guzik Technical Enterprises Phase frequency response measurement method
GB2608645A (en) * 2021-07-09 2023-01-11 Reckitt Benckiser Health Ltd Novel use of polymer combination
GB2625584A (en) * 2022-12-21 2024-06-26 Rb Health Us Llc Novel composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0818154A (ja) * 1994-07-04 1996-01-19 Japan Aviation Electron Ind Ltd ２波長半導体レーザ
EE03902B1 (et) 1996-05-20 2002-12-16 Janssen Pharmaceutica N.V. Osakesed, nende valmistamismeetod ja kasutamine, farmatseutiline doseerimisvorm ja selle valmistamismeetod, tahke dispersioon ning farmatseutiline pakend
WO1999033467A1 (en) * 1997-12-31 1999-07-08 Choongwae Pharma Corporation Method and composition of an oral preparation of itraconazole
CA2359945C (en) * 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
DE10038571A1 (de) 2000-08-03 2002-02-14 Knoll Ag Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen

Also Published As

Publication number Publication date
US7407670B2 (en) 2008-08-05
WO2004004683A8 (en) 2004-11-25
CA2489071A1 (en) 2004-01-15
WO2004004683A1 (en) 2004-01-15
NZ536975A (en) 2006-10-27
NO20050506L (no) 2005-01-28
US20060062809A1 (en) 2006-03-23
CN1318019C (zh) 2007-05-30
JP2005538973A (ja) 2005-12-22
AU2003246351A1 (en) 2004-01-23
AU2003246351B2 (en) 2009-02-19
CN1665483A (zh) 2005-09-07
EP1521571A1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
HK1080373A1 (en) Solid dispersion comprising two different polymer matrixes
AU2003293082A1 (en) Antioxidant-functionalized polymers
SI1675622T1 (sl) Večkraka polimerna predzdravila
HK1072950A1 (zh) 遇水膨脹的聚合物
AU2003252245A1 (en) Solid polymer electrolyte
AU2003297458A1 (en) Polymerization processes
AU2003207801A1 (en) Antimicrobial polymer
AU2003274121A1 (en) 3,4-alkylenedioxythiophene compounds and polymers thereof
GB0216333D0 (en) Substance - selective polymer membranes
GB0321383D0 (en) Polymer circuits
DE60333033D1 (en) Pulverförmiges thermoplastisches polymer
AU2003297977A1 (en) Releasable polymer arrays
GB0323733D0 (en) Conductive polymer
AU2003902868A0 (en) Muscle assessment
AU2003221807A1 (en) Polymeric hydrogels
GB2393446B (en) Polymer
HK1092171A1 (en) Polymer networks
AU2003251274A1 (en) Waterborne homo or copolymer dispersion
AU2003903838A0 (en) Aqueous polymer dispersion
AU2003303475A1 (en) Polymerization processes
AU2002304998A1 (en) Rope hitch
AU2002349821A1 (en) Boat-anchoring equipment
AU2003201037A1 (en) Highly functional polymers
GB0309010D0 (en) Polymer networks
GB0326138D0 (en) Polymers, their preparation and uses

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110701